Phase 3 Completed N=38 Treatment

Evaluation of the Performance of Non-molded Soft Contact Lenses

ametropia

Source: ClinicalTrials.gov NCT00371787 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2010

Primary outcomePrimary: Visual Acuity — 0.01; -0.07 logMAR

Summary

To evaluate the performance of the study soft lens for vision, comfort, physiology and lens surface properties.

Outcome Measures

Outcome	Result	p-value
PRIMARY Visual Acuity	0.01; -0.08	—
PRIMARY Neovascularisation	0.84; 0.35	—
PRIMARY Neovascularization	0.63; 0.35	—

Eligibility Criteria

Inclusion Criteria

Male or female, good health, age >17yrs, able to wear contact lenses as primary vision correction, able to see well and achieve good fit with study lens, has understood & signed consent form.

Exclusion Criteria

Has active ocular disease, uses topical eye medication, wears gas permeable/silicone hydrogel /overnight wear contact lenses, is a participant in another clinical study, is deemed unsuitable for soft contact lens wear.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00371787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.